Isolated low levels of HDL-C associated with increased risk of CHD
Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease - An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific RegionRachel R. Huxley, et al, for the Asia Pacific Cohort Studies Collaboration and the Obesity in Asia Collaboration
Circulation. 2011 DOI: 10.1161/CIRCULATIONAHA.111.028373
Previous studies have suggested that there is a novel dyslipidemic profile consisting of isolated low high-density lipoprotein cholesterol (HDL-C) level that is associated with increased risk of coronary heart disease, and that this trait may be especially prevalent in Asian populations.
Individual participant data from 220 060 participants (87% Asian) in 37 studies from the Asia-Pacific region were included. Low HDL-C (HDL < 1.03 mmol/L in men and < 1.30 mmol/L in women) was seen among 33.1% (95% confidence interval [CI], 32.9 –33.3) of Asians versus 27.0% (95% CI, 26.5–27.5) of non-Asians (P<0.001). The prevalence of low HDL-C in the absence of other lipid abnormalities (isolated low HDL-C) was higher in Asians compared with non-Asians: 22.4% (95% CI, 22.2–22.5) versus 14.5% (95% CI, 14.1–14.9), respectively (P<0.001). During 6.8 years of follow-up, there were 574 coronary heart disease and 739 stroke events. There was an inverse relationship between low HDL-C with coronary heart disease in all individuals (hazard ratio, 1.57; 95% CI, 1.31–1.87). In Asians, isolated low levels of HDL-C were as strongly associated with coronary heart disease risk as low levels of HDL-C combined with other lipid abnormalities (hazard ratio, 1.67 [95% CI, 1.27–2.19] versus 1.63 [95% CI, 1.24 –2.15], respectively). There was no association between low HDL-C and stroke risk in this population (hazard ratio, 0.95 [95% CI, 0.78 to 1.17] with nonisolated low HDL-C and 0.81 [95% CI, 0.67–1.00] with isolated low HDL-C).
Methods and Results
Isolated low HDL-C is a novel lipid phenotype that appears to be more prevalent among Asian populations, in whom it is associated with increased coronary risk. Further investigation into this type of dyslipidemia is warranted.
The associations of LDL-C and HDL-C with CHD risk are clear in several populations [1-3]. The importance of HDL-C independent of LDL-C for coronary risk determination is also apparent [4,5]. Isolated low HDL-C in combination with normal TG- and LDL-C levels could be a similar coronary risk as elevated LDL-C [6-8]. These individuals often remain untreated because of their normal LDL-C and total cholesterol levels. This phenotype might especially be common in Asian populations, which is being investigated in this study using data from APCSC (Asia Pacific Cohort Studies Collaboration (APCSC) and OAC (Obesity in Asia Collaboration). Information was available on 69 145 eligible study participants from 24 studies from the APCSC and 150 915 from 13 studies in the OAC. Overall, 87% of men and 86% of women were from Asia.
- ↑ BMI
- ↑ waist circumference
- ↑ DM
There was no association between low HDL-C and stroke risk in this population.
Isolated low HDL-C level is a common phenotype in Asian populations, associated with an increased risk of CHD. Individuals with this lipid abnormality are unlikely to receive lipid-lowering medications because their TG levels and LDL-C meeting guideline targets. In these regions, HDL-C increasing strategies might potentially be beneficial, such as smoking cessation, weight loss, physical activity, and the use of niacin / fibrates.
Newly developed CETP inhibitors may become very important for CV prevention in this region!
1. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293–298.
2. Tunstall-Pedoe H, Woodward M, Tavendale R, A’Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study. BMJ. 1997;315:722–729.
3. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, Komachi Y. High density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994;89:2533–2539.
4. Woodward M, Barzi F, Feigin V, Gu D, Huxley R, Nakamura K, Patel A, Ho S, Jamrozik K; Asia Pacific Cohort Studies Collaboration. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007;28: 2653–2660.
5. Gordon DJ, Probstfield JL. Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8 –15.
6. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol. 1997;17:107–113.
7. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J. 1998;19(suppl A):A2–A11.
8. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol. 1995;75:1189 –1195.